Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | ($33.6K) | $0.0 | ($22.4K) | ($22.4K) | ($27.2K) | ($27.4K) | ($28.7K) | ($17.1M) | ($17.0M) | ($21.4M) | ($10.4M) | ($23.3M) | ($3,478.0K) | ($110.1M) | ($57.0M) | ($65.8M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Aadi Bioscience, Inc.'s last 12-month Net Income is ($61.7M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Aadi Bioscience, Inc.'s Net Income growth was (0.3%). The average annual Net Income growth rates for Aadi Bioscience, Inc. have been 46.4% over the past three years, 17.7% over the past five years.
Over the last year, Aadi Bioscience, Inc.'s Net Income growth was (0.3%), which is lower than industry growth of (0.1%). It indicates that Aadi Bioscience, Inc.'s Net Income growth is Bad.